About
Eric Floyd is a life sciences executive with experience in drug development, regulatory strategy, and quality management across the industry. He has worked on fast-track approvals and securing worldwide regulatory clearances, and has built relationships with global regulatory authorities. Floyd currently serves as a member of the Board of Directors at the University of Illinois Alumni Association and has incorporated AI technologies into regulatory and manufacturing processes.
Experience
- University of Illinois Alumni AssociationMember of the Board of Directorscurrent2025 β presentUrbana-Champaign Area
- Meharry Medical CollegeMember of the Board of Trusteescurrent2010 β presentNashville, Tennessee, United States
- Floyd Regulatory Strategic ConsultingPrincipal & CEOcurrent2018 β presentGreater New York City Area
- Silence Therapeutics plcChief Regulatory Officer2024 β 2025New York, NY
- Silence Therapeutics plcSenior Vice President Regulatory Affairs & Quality Assurance2020 β 2024New York, NY
- Virpax Pharmaceuticals Inc. (Nasdaq:VRPX)Chairman of the Board2023 β 2024Malvern, Pennsylvania, United States
- Virpax Pharmaceuticals Inc. (Nasdaq:VRPX)Director, Member of the Board - Chair of Compensation & Scientific and Reg Advisory Committees2018 β 2024Berwyn, PA
- Neurogene Inc.Chief Regulatory Officer2018 β 2019Greater New York City Area
- Axovant SciencesSenior Vice President Global Regulatory Affairs2017 β 2018Greater New York City Area
- Dohmen Life Science ServicesPresident of Compliance Services & Chief Scientific Officer2015 β 2017Milwaukee, WI
- LundbeckVice President Regulatory Affairs and Quality Assurance2011 β 2015Deerfield, Illinois, United States
- HospiraVice President, Global Regulatory Affairs2010 β 2012Lake Forest, Illinois, United States
- CephalonVice President Worldwide Regulatory Affairs2007 β 2010Frazer Township, Pennsylvania, United States
- NovartisVice President & Global Head DRA2005 β 2007Basel-Country, Switzerland
- SanofiSenior Director Regulatory Affairs - Theapeutic Area Head2001 β 2004Paris, Ile-de-France, France
- MerckAssociate Director1998 β 2001Blue Bell, Pennsylvania, United States
Education
- Harvard Medical SchoolFaculty
- INSEADGlobal Executive MBA, International Business Relations
- Meharry Medical CollegePh.D., Neurophysiology
- Saint Joseph's UniversityExecutive MBA, Pharmaceutical Marketing
- Tennessee State UniversityM.Sc., Neurocience
- University of Illinois Urbana-ChampaignB.S., Biology
- Wake Forest Biomedical Graduate ProgramsPost Doctoral Research
Skills & more
Strategy99IND74Regulatory Approvals6Asset Evaluation5Hospital Sales22Business Development35Mergers20Regulatory Affairs99FDA99Quality Assurance58Pharmaceutics99Oncology95
+12 more
Clinical TrialsClinical DevelopmentBiotechnologyDrug DevelopmentPharmacovigilanceSopGMPBiopharmaceuticalsRegulatory SubmissionsTherapeutic AreasPharmaceutical Industry21 CFR Part 11Languages English
From Eric's professional profile.
Colleagues at 2Flo Ventures
Amanda Johnson
Venture Fellow at 2Flo Ventures
Amanda Waldhauser
Executive Director at Roivant Social Ventures at 2Flo Ventures
Angela James
Senior Advisor at 2Flo Ventures
Azurii Collier
Commercial Advisor at 2Flo Ventures
Brenda Ametepe
Venture Fellow at 2Flo Ventures
Charlotte Jones-Burton
Partner at 2Flo Ventures
Christina Broomes
Commercial Advisor at 2Flo Ventures
Christopher Whitfield
Strategic Advisor at 2Flo Ventures
Frequently asked questions
- Where does Eric Floyd work?
- Eric Floyd is Regulatory Advisor at 2Flo Ventures.
Same school
Also attended Harvard Medical School135
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 129 more
Also attended Saint Joseph's University14
Nick ZurickTalent Lead at Pantera CapitalScott NissenbaumPresident & CEO at Ben Franklin Technology PartnersChristine BetarFund Controller at HeadlineEvan CampbellInvestor at Susquehanna Growth EquityTom DoughertySmarter Technologies at Empactful CapitalYvette BrightBrighter Horizon Foundation at Empactful Capital
+ 8 more
Also attended Tennessee State University6
Also attended Wake Forest Biomedical Graduate Programs1
Shared employers
Also worked at Neurogene Inc.1
Also worked at Hospira3
Also worked at Novartis126
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 120 more
Also worked at Sanofi91
Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures
+ 85 more

















.png)









.v1.v1.jpg)












)


